NCT06735287View on ClinicalTrials.gov

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 31, 2027

Conditions
Bladder CancerNMIBC
Interventions
PROCEDURE

bladder sparing set

after neoadjuvant chemotherapy combined with immunotherapy, maximal TURBT and a re-TURBT shall be performed then mitomycin C bladder instillation therapy will be administered

PROCEDURE

RC

Radical cystectomy performed immediately after three cycles of neoadjuvant therapy.

Trial Locations (1)

210000

RECRUITING

The first affiliated hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER